Wegovy Regret, Stopping, and Restarting: What Real Users and Clinical Trials Actually Show At a glance Drug / semaglutide 2.4 mg (Wegovy), weekly subcutaneous injection Weight regain after stopping / ~two-thirds of lost weight returns within 12 months (STEP-4 withdrawal data) Average weight loss on treatment / 14.9% body weight at 68 weeks in STEP-1 (N=1,961) Restart titration / always begin at 0.25 mg/week regardless of prior dose Most common regret trigger / GI side effects, cost (~$1,300/month without insurance), and inadequate response Re-titration schedule / 4 weeks per dose level (same as initial prescribing label) Discontinuation rate in STEP-1 / 7.3% semaglutide arm vs
Avoid alcohol during dose escalation when your body is still adjusting and GI side effects are at their peak
Through rigorous synthesis and analysis of available data, we aimed to provide valuable insights into the safety profile of GLP-1 RAs in this distinct patient population
Held to the same sourcing and third-party testing standard
Cooper, a show idea, feedback, or just want to connect
This includes watching for signs of fever, such as: Increased body temperature Chills or shivering Sweating more than usual Feeling unusually tired or weak Muscle aches By paying attention to these signs, you can catch any issues early and address them before they become serious